Scientists discover genetic variant in some beta-thalassemia patients

02/4/2008 | News-Medical.Net

Scientists have discovered a variation in the BCL11A gene that could explain why some people with beta-thalassemia experience less severe symptoms and do not need to undergo frequent blood transfusions. Researchers say the gene could be explored as a potential intervention to treat hemoglobin deficiencies.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI